{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:22:17Z","timestamp":1786659737264,"version":"build-2736575974"},"reference-count":33,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007174","name":"Array BioPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.1021\/acs.molpharmaceut.3c00016","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T22:09:32Z","timestamp":1681164572000},"page":"2589-2599","source":"Crossref","is-referenced-by-count":22,"title":["Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An <i>In Vivo<\/i>\u2013<i>In Vitro<\/i>\u2013<i>In Silico<\/i> Approach"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1174-966X","authenticated-orcid":true,"given":"Joseph","family":"Piscitelli","sequence":"first","affiliation":[{"name":"Pfizer Inc., Global Product Development, La Jolla, California 92121, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-9843","authenticated-orcid":true,"given":"Bart","family":"Hens","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Drug Product Design, Sandwich CT13 9NJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Tomaszewska","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Drug Product Design, Sandwich CT13 9NJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Wollenberg","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Early Clinical Development, Boulder, Colorado 80301, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Litwiler","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Global Product Development, Boulder, Colorado 80301, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"McAllister","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Drug Product Design, Sandwich CT13 9NJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-3714","authenticated-orcid":true,"given":"Micaela","family":"Reddy","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Early Clinical Development, Boulder, Colorado 80301, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30142-6"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30497-2"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1915676"},{"key":"ref4\/cit4","unstructured":"BRAFTOVI (encorafenib) capsules, for oral use (Full Pescribing Information); Array BioPharma Inc., 2018."},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.04.013"},{"key":"ref6\/cit6","unstructured":"Assessing the Effects of Food on Drugs in INDs and NDAs \u2013\nClinical Pharmacology Considerations; Docket Number FDA-2018-D-4368; U.S. Department of Health and Human Services, 2019."},{"key":"ref7\/cit7","unstructured":"Guidance Document: Evaluation\nof Gastric pH-Dependent Drug Interactions\nWith Acid-Reducing Agents: Study Design, Data Analysis, and Clinical\nImplications Guidance for Industry; Docket Number FDA-2020-D-1794; U.S. Department of Health and Human Services, 2020."},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1177\/026119299502300205"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.3920\/BM2016.0196"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.3109\/17435390.2014.948091"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.22805"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.07.053"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.10.009"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2015.1135935"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/bm500927r"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02849976"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/mp5007322"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.11.048"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00253"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.07.003"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.10.010"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1678"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.05.024"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00508-2"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24177"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9333-x"},{"key":"ref27\/cit27","first-page":"37","volume-title":"Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models","author":"Minekus M.","year":"2015"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00807"},{"key":"ref29\/cit29","unstructured":"Del Frari, L.; Lukacova, V.; Reddy, M. Building of Encorafenib Physiologically Based Pharmacokinetic Model and its Qualification to Predict Drug Drug Interaction with CYP3A4 Inhibitors.  MIDD+ 2023; February 16, 2023; Virtual Poster 41. https:\/\/www.simulations-plus.com\/resource\/real-world-impact-regulatory-decision-making-track-poster-presentation-building-of-encorafenib-physiologically-based-pharmacokinetic-model-and-its-qualification-to-predict-drug-drug-interaction-wit\/ (Accessed March 28, 2023)."},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1021\/mp500210c"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.09.014"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1973.tb08339.x"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2923"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00016","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T08:11:24Z","timestamp":1682928684000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.3c00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"alternative-id":["10.1021\/acs.molpharmaceut.3c00016"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00016","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]}}}